Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

CUSIP: 816212302

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
26,658,100
Total 13F shares
5,968,086
Share change
-433,710
Total reported value
$60,898,831
Put/Call ratio
20%
Price per share
$10.22
Number of holders
65
Value change
-$4,440,064
Number of buys
26
Number of sells
24

Security key

816212302

Report period

Q3 2025

Institutions

65

Top holders

10

Top shareholders of RNAC - Cartesian Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Timothy A. Springer
13D/G
37%
9,555,394
$116,671,361 +$258,583 13 Jan 2025
JPMORGAN CHASE & CO
13D/G 13F
Company
6.1%
1,675,636
$20,459,516 $0 31 Mar 2025
FMR LLC
13F
Company
8.8%
2,334,124
$24,251,549 30 Jun 2025
13F
MPM BioImpact LLC
13F
Company
2.6%
686,007
$7,127,613 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
2.5%
653,840
$6,793,398 30 Jun 2025
13F
Siren, L.L.C.
13F
Individual
2.1%
563,272
$5,852,396 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
1.9%
496,366
$5,157,243 30 Jun 2025
13F
Erste Asset Management GmbH
13F
Company
0.98%
260,011
$2,702,548 30 Jun 2025
13F
683 Capital Management, LLC
13F
Company
0.82%
219,000
$2,275,411 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.82%
218,927
$2,275,016 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.73%
194,269
$2,018,455 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.45%
120,874
$1,255,881 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.31%
82,944
$861,789 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
0.31%
82,630
$858,526 30 Jun 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.16%
41,602
$432,000 30 Jun 2025
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.15%
41,317
$429,284 30 Jun 2025
13F
BARCLAYS PLC
13F
Company
0.12%
30,675
$318,713 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.11%
29,213
$303,523 30 Jun 2025
13F
Freestone Capital Holdings, LLC
13F
Company
0.1%
25,921
$269,319 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.09%
24,981
$259,552 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.09%
24,903
$258,742 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.09%
24,497
$254,524 30 Jun 2025
13F
Ikarian Capital, LLC
13F
Company
0.08%
22,166
$230,304 30 Jun 2025
13F
DELPHI FINANCIAL GROUP, INC.
13F
Company
0.08%
22,028
$228,871 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.07%
19,500
$202,605 30 Jun 2025
13F
TWIN FOCUS CAPITAL PARTNERS, LLC
13F
Company
0.07%
19,000
$197,410 30 Jun 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.07%
18,300
$190,000 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.05%
13,933
$144,765 30 Jun 2025
13F
UBS Group AG
13F
Company
0.05%
13,206
$137,210 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.05%
13,171
$136,836 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
11,895
$123,589 30 Jun 2025
13F
Miller Financial Services LLC
13F
Company
0.04%
11,643
$120,971 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
11,570
$120,212 30 Jun 2025
13F
Virtus Investment Advisers, LLC
13F
Company
0.03%
9,183
$95,411 30 Jun 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.03%
7,424
$77,135 30 Jun 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
5,833
$60,605 30 Jun 2025
13F
China Universal Asset Management Co., Ltd.
13F
Company
0.02%
5,213
$54,163 30 Jun 2025
13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
13F
Company
0.02%
5,056
$52,532 30 Jun 2025
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.02%
4,718
$11,089 30 Jun 2025
13F
AlphaQuest LLC
13F
Company
0.02%
4,207
$43,711 30 Jun 2025
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
3,902
$40,542 30 Jun 2025
13F
CITIGROUP INC
13F
Company
0.01%
3,629
$37,705 30 Jun 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
2,985
$31,014 30 Jun 2025
13F
Police & Firemen's Retirement System of New Jersey
13F
Company
0.01%
2,939
$30,536 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.01%
1,378
$14,317 30 Jun 2025
13F
ALERUS FINANCIAL NA
13F
Company
0%
1,000
$10,390 30 Jun 2025
13F
Legal & General Group Plc
13F
Company
0%
938
$9,746 30 Jun 2025
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0%
766
$7,959 30 Jun 2025
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
708
$7,356 30 Jun 2025
13F
GF FUND MANAGEMENT CO. LTD.
13F
Company
0%
650
$6,754 30 Jun 2025
13F

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q3 2025

As of 30 Sep 2025, Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,968,086 shares. The largest 10 holders included FMR LLC, BlackRock, Inc., Siren, L.L.C., VANGUARD GROUP INC, MPM BIOIMPACT LLC, Erste Asset Management GmbH, GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 66 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
65
Q3 2025 holders
65
Holder diff
0
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .